Published in Circ Arrhythm Electrophysiol on June 01, 2012
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.02
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation (2002) 9.02
n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med (2010) 7.58
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation (2010) 4.60
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA (1995) 3.48
Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation (2003) 3.42
Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr (2003) 3.38
Fish consumption and risk of sudden cardiac death. JAMA (1998) 3.06
Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation (2003) 2.88
Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation (2006) 2.52
Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12
Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol (2006) 1.68
Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation (1999) 1.65
Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci U S A (1994) 1.62
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation (2005) 1.56
Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J (1992) 1.37
Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol (1985) 1.18
Pro- and antiarrhythmic properties of a diet rich in fish oil. Cardiovasc Res (2006) 1.13
Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res (2006) 1.07
Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: lack of protection and a proarrhythmic effect. Circ Arrhythm Electrophysiol (2012) 0.95
A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism (2005) 0.91
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73
Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med (2006) 4.16
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol (2009) 3.99
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA (2002) 3.60
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation (2003) 3.50
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol (2010) 2.96
Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94
Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA (2011) 2.34
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA (2008) 2.32
Birth weight is a significant risk factor for incident atrial fibrillation. Circulation (2010) 2.30
Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation (2006) 2.26
Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. J Am Coll Cardiol (2010) 2.12
Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am J Clin Nutr (2009) 2.04
Novel genetic markers improve measures of atrial fibrillation risk prediction. Eur Heart J (2013) 1.93
Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm (2008) 1.85
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med (2009) 1.83
Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol (2009) 1.79
Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm (2011) 1.76
Physical exertion, exercise, and sudden cardiac death in women. JAMA (2006) 1.76
Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation (2009) 1.74
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr (2004) 1.70
Epidemiology and genetics of sudden cardiac death. Circulation (2012) 1.65
Light-to-moderate alcohol consumption and risk of sudden cardiac death in women. Heart Rhythm (2010) 1.61
A common variant at 9p21 is associated with sudden and arrhythmic cardiac death. Circulation (2009) 1.59
Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. Int J Cardiol (2013) 1.57
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation (2005) 1.56
Alcohol consumption and risk of incident atrial fibrillation in women. JAMA (2008) 1.55
Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50
A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death. Heart Rhythm (2013) 1.47
The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants. J Womens Health (Larchmt) (2004) 1.44
Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr (2008) 1.42
Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet (2011) 1.38
Electrocardiographic left ventricular scar burden predicts clinical outcomes following infarct-related ventricular tachycardia ablation. Heart Rhythm (2013) 1.38
Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol (2005) 1.37
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37
Ventricular arrhythmias and sudden cardiac death. Lancet (2012) 1.29
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J (2010) 1.23
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. Circulation (2009) 1.22
Catheter ablation for paroxysmal atrial fibrillation. N Engl J Med (2012) 1.17
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial. Diabetes (2009) 1.16
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation (2014) 1.11
Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation (2013) 1.11
Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. Am J Cardiol (2003) 1.09
Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol (2007) 1.05
Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr (2010) 1.04
Catheter ablation of peri-AV nodal atrial tachycardia from the noncoronary cusp of the aortic valve. J Cardiovasc Electrophysiol (2007) 1.02
Dietary fat quality and risk of sudden cardiac death in women. Am J Clin Nutr (2012) 1.02
Waist-height ratio as a predictor of coronary heart disease among women. Epidemiology (2009) 1.01
Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women. Atherosclerosis (2005) 0.98
Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr (2010) 0.92
Dietary and plasma magnesium and risk of coronary heart disease among women. J Am Heart Assoc (2013) 0.91
Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J Am Heart Assoc (2014) 0.91
Type 2 diabetes mellitus and risk of incident atrial fibrillation in women. J Am Coll Cardiol (2012) 0.91
Folate intake and risk of stroke among women. Stroke (2004) 0.91
Physical activity and the risk of incident atrial fibrillation in women. Circ Cardiovasc Qual Outcomes (2011) 0.90
A common variant in the β2-adrenergic receptor and risk of sudden cardiac death. Heart Rhythm (2011) 0.90
Survival in octogenarians receiving implantable defibrillators. Am Heart J (2006) 0.89
Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease. PLoS One (2013) 0.87
Global Psychological Distress and Risk of Atrial Fibrillation Among Women: The Women's Health Study. J Am Heart Assoc (2012) 0.87
Intake of total trans, trans-18:1, and trans-18:2 fatty acids and risk of sudden cardiac death in women. Am Heart J (2009) 0.86
A trial of omega-3 fatty acids for prevention of hypertension. Am J Cardiol (2004) 0.86
Para-Hisian entrainment: a novel pacing maneuver to differentiate orthodromic atrioventricular reentrant tachycardia from atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol (2003) 0.86
Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation (2004) 0.85
Causes and prevention of sudden cardiac death in the elderly. Nat Rev Cardiol (2013) 0.85
Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ Arrhythm Electrophysiol (2012) 0.84
Relation of renal function to risk for incident atrial fibrillation in women. Am J Cardiol (2011) 0.83
Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation (2004) 0.83
Omega-3 fatty acids and ventricular arrhythmias: nothing is simple. Am Heart J (2008) 0.82
Sleep duration and risk of atrial fibrillation (from the Physicians' Health Study). Am J Cardiol (2012) 0.82
Vitamin E supplementation and the risk of heart failure in women. Circ Heart Fail (2012) 0.81
Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. J Cardiovasc Electrophysiol (2004) 0.81
Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. Eur Heart J (2007) 0.78
Prediction of sudden cardiac death in patients with coronary heart disease: the challenge ahead. Circ Cardiovasc Imaging (2008) 0.75
N-terminal pro-B-type natriuretic peptide and sudden cardiac death risk: implications for primary prevention of sudden cardiac death. Heart Rhythm (2010) 0.75
Cardiac resynchronization therapy and proarrhythmia: weathering the storm. J Cardiovasc Electrophysiol (2008) 0.75
Alcohol consumption and risk of atrial fibrillation. J Am Coll Cardiol (2011) 0.75
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet (2017) 0.75
Resetting criteria during ventricular overdrive pacing successfully differentiate orthodromic reentrant tachycardia from atrioventricular nodal reentrant tachycardia despite interobserver disagreement concerning QRS fusion. Heart Rhythm (2010) 0.75